explore -WSS

explore

author：explore 2025-10-01 17:19:58 - browse：5

James Comer (R-KY) walks on the House side of the U.S. Capitol on May 14, 2024 in Washington, DC — Rep. James Comer (R-Ky.), the chair of the House Committee on Oversight and Accountability, has taken an interest in pharmacy benefit managers. Kent Nishimura/Getty Images

WASHINGTON — Executives from the three major pharmacy benefit manager companies have been invited to testify before the House Committee on Oversight and Accountability next month, four sources familiar with the planning told STAT.

Executives from Optum, CVS Caremark, and Express Scripts, owned by Cigna, were asked to testify before the panel on June 4.

The committee and companies did not respond to requests for comment.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Micronoma's microbiome cancer diagnostic approach under fire

explore

WSS

Synthetic human embryos? Researchers say term is overblown

Lilly’s obesity pill cuts 15% of weight at highest dose in mid

Supreme Court strikes down Biden student loan forgiveness program

Medical experts exlpore how to eliminate bias in clinical algorithms

The simple reason for the increase in autism diagnosis

‘Oppenheimer’ and the risks of AI in health care

focus

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Wikipedia

Activists slam private health insurers over coverage restrictions

Biden slams SCOTUS affirmative action decision: 'Discrimination still exists in America'

23andMe had bad news about my health. I wish a person had delivered it

Synthetic human embryos? Researchers say term is overblown

United colonoscopy coverage change 'may cost lives,' doctors say

New safety details link Apellis eye drug to rare cases of blindness

In Memoriam: Notable people who died in 2023

Lilly’s obesity pill cuts 15% of weight at highest dose in mid

Psychedelics group wrestles with new pharma identity

Micronoma's microbiome cancer diagnostic approach under fire

hotspot

Illumina to lay off 10% of research and development team

Physician groups backed by private equity giant lobby on mergers

The sun may be out, but guns are not. A lawsuit challenges a new gun ban on Hawaii beaches

The strange history of BMI, the body mass index

Ukrainian soldiers say they owe lives to US

Wildfire pollution widens asthma inequities on Long Island

hotspot

hotspot

explore

Wikipedia